Skip to main content

With a combined 100+years’ experience in key markets and experience spanning more than 15 countries across its partners and senior associates in Anadach Group, CHS has a unique ability to provide high quality, realistic data-driven market demand and supply diagnostics that use standardized tools, primary surveys, as well as the clinical health and supply chain expertise required to provide uniquely informative market assessments. 

Select Project profiles: 

  • Supporting market entry strategy for big pharma in Kenya and Nigeria: Collaboration with Alcimed, a pharmaceutical consultancy firm based out of Belgium to conduct an Africa Regional Strategy for Bayer focused on key products of interest for Kenya, Nigeria across two phases and one year.
  • Market demand assessment for COVID-19 vaccination in Rwanda, Kenya and Ethiopia: In collaboration with Anadach group, CHS led COVID-19 situational Analysis in Rwanda, Kenya and Ethiopia as well as supporting a ”go-to-market” strategy for Pfizer between 2020 and 2021.
  • Supporting market growth strategy for a lab business in Ethiopia: Retained Technical advisor to ICL laboratory business and the Bill And Melinda Gates Foundation in ensuring implementation of a PPP model for Laboratory services with regional public hospitals in Ethiopia, as well as the monitoring and development of a COVID Impact plan assessment.
  • Supporting market intelligence and data gathering for private sector engagement models in Ethiopia: CHS advises several agencies such as WHO, Intrahealth and Chemonics in identifying market data and intelligence for supporting project design and RFP development in private sector in health and PPP models.